Dark
Light
System
Security
Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.. Institutional holdings reported to the SEC.

Institutional Holders (2014Q3)
Portfolio Summary: 3 Institutional holders with a total value of $1,545,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 DOHENY ASSET MANAGEMENT /CA 80,555 733,000 47.44%
2 Belmont Global Advisors, Inc. 47,300 430,000 27.83%
3 J.P. Morgan Private Wealth Advisors LLC 42,000 382,000 24.72%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.